Navigation Links
Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference

ditional potential to effectively treat avian flu in those already infected."

About Hemispherx Biopharma

Hemispherx Biopharma, Inc. is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx's flagship products include Alferon N Injection(R) and the experimental therapeutics Ampligen(R) and Oragens(R). Alferon N Injection(R) is approved for a category of STD infection, and Ampligen(R) and Oragens(R) represent experimental RNA nucleic acids being developed for globally important viral diseases and disorders of the immune system. Hemispherx's platform technology includes large and small agent components for potential treatment of various severely debilitating and life threatening diseases. Hemispherx has in excess of 100 patents comprising its core intellectual property estate, a fully commercialized product (Alferon N Injection(R)) and GMP certified manufacturing facilities for its novel pharma products. For more information please visit www.hemispherx.net.

Information contained in this news release other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risk of competition, changing market conditions, change in laws and regulations affecting these industries and numerous other factors discussed in this release and in the Company's filings with the Securities and Exchange Commission. Any specifically referenced investigational drugs and associated technologies of the Company (including Ampligen(R), Alferon LDO and Oragens) are experimental in nature and as such are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials with the referenced disorders. The forward-looking statements represent the Company's judgment as of the date of
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Hemispherx Presents Evidence of Ampligen Synergies with Existing Antivirals at International Avian Influenza Conference
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein

Post Your Comments:
(Date:11/6/2009)...RNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc....that is developing and marketing Levulan(®) P...ed on patients with common skin conditions, announ...Officer, will present a corporate overview at the ...ay, November 10, 2009 at 10:00 a.m. ET at the Hote...
(Date:11/6/2009)...wswire/ -- Repossessions and liquidations of truck...er of 2009 declined as compared to similar figures... NasTrac Quarterly Index (NQI). The figures, cull...possessions and orderly liquidations, also indicat...nd printing equipment, offering mixed news on the ...
(Date:11/6/2009)...re-USNewswire/ -- America,s Specialty Medicines Co...arket and smaller innovator pharmaceutical compani..."Affordable Health Care for America Act," introduc...r companies fear that the cumulative effect of a h...fforts to bring new medicines to market. ,, F...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 59706 1New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 59706 2New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 59706 3New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 59706 4Fate Therapeutics announces creation of small molecule platform for commercial scale reprogramming 10409 1Fate Therapeutics announces creation of small molecule platform for commercial scale reprogramming 10409 2Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 1Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 2Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 3
...nce of Severe Cardiac Toxicity With Equivalent ... ATLANTA, Dec. 11 Cell Therapeutics, Inc.,(CTI) (...inary data from,its phase II/III randomized study ...ment of patients with aggressive non-Hodgkin,s lym...e experienced less severe,(grade 3/4) toxicities i...
... Dec. 10 CSG/SportsCoatings and,the National Wres...,partnership that brings the most proactive and pr...gi to the wrestling community., Nationally renown...hibits and controls the growth of microbial contam...cs for extended periods of time;,CSG/SportsCoating...
Other Medicine Technology:Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5National Wrestling Coaches Association Teams Up With CSG/SportsCoatings(TM) 2
(Date:11/8/2009)...traight-back, chest-out position promotes self-ass...8 (HealthDay News) -- Your mother may have been ri...arch suggests that good posture could make you fee...of us were taught that sitting up straight gives a...co-author of the study and a psychology professor ...
(Date:11/8/2009)..., WASHINGTON, Nov. 7 ...ffordable Health Care for America Act, landmark he...rican has access to quality, affordable, stable an...ich cracks down on some of the insurance industry,...lion Americans and cut the deficit by $104 billion...
(Date:11/8/2009)... A jury of 8 people in the...County woman $2,300,000 in pain and suffering for ...ney, James Tallman and Alicia Nocera of Thomas E. ...half of the plaintiff, Vita Monestersky and agains...n emergency total abdominal hysterectomy at age 18...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...ica (PhRMA) Senior Vice President Ken Johnson rele...ealth care reform bill: ,, "We are disappointed...ss echoed by millions of hardworking Americans as ...se of Representatives who voted against the bill. ...
(Date:11/8/2009)..., AARP Praises House Passage of Health Care Re...gthen Medicare, improve coverage for all Americans...-- SUMMARY: Tonight the United States House of R...legislation that would strengthen Medicare for sen... that prices millions of Americans out of affordab...
Breaking Medicine News(10 mins):Health News:Good Posture May Inspire Confidence 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3
...ssure the Safety and Purity ...The U.S. Pharmacopeia (USP),today announced the re...Codex (FCC), a compendium that sets standards for ...ves and processing,aids., The new edition is the ...
...received a five-year, $20.5 million grant from the...rnational program investigating the biological fac...virus that causes AIDS. The grant provides suppor...ering information that can guide design of a vacci...
... WASHINGTON, March 4 To meet increased needs,for...hose returning from,the Global War on Terror, the ...ts training programs for psychologists., "Not all... for mental health services. This initiative meets...
...xperience a significant improvement in their quali...according to new research published in the March 2.... , The German study evaluated the quality of lif...t sound perception, speech, self-esteem, and socia...
...closely related strains of the influenza A virus m...cs, according to biologists. The findings could he...and others lead to seasonal epidemics., Until now,...uch as the Spanish flu of 1918, the Asian flu of 1...
...cal Efficiency and Accuracy, TEL AVIV, Israel, Ma...edic pre-operative digital templating software, an... online service that streamlines,the supply and se...an use a wireless Bluetooth or,PC-connected scanne...
Other Medicine News:Health News:U.S. Pharmacopeia Releases New Edition of the Food Chemicals Codex 2Health News:Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study 2Health News:Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study 3Health News:VA to Train More Psychologists 2Health News:Study uncovers cause of flu epidemics 2Health News:Study uncovers cause of flu epidemics 3Health News:Orthocrat Teams up With WebOps to Advance Orthopedic Pre-Surgery Planning 2
...de; HME product line has the right product for any...m intubated patients to patients with tracheotomie...r both anesthesia and critical care applications.,...um protection for patients and staff members. This...
...de; HME product line has the right product for any...m intubated patients to patients with tracheotomie...r both anesthesia and critical care applications.,...um protection for patients and staff members. This...
High Performance HME with Port
Breathe-Easy™ with Suction Valve for Tracheotomies
Medicine Products: